COR vs. CAH, MCK, ALC, IDXX, HUM, IQV, CNC, TAK, HLN, and DXCM
Should you be buying Cencora stock or one of its competitors? The main competitors of Cencora include Cardinal Health (CAH), McKesson (MCK), Alcon (ALC), IDEXX Laboratories (IDXX), Humana (HUM), IQVIA (IQV), Centene (CNC), Takeda Pharmaceutical (TAK), Haleon (HLN), and DexCom (DXCM). These companies are all part of the "medical" sector.
Cardinal Health (NYSE:CAH) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, community ranking, risk, earnings, institutional ownership, media sentiment, profitability, valuation and analyst recommendations.
Cardinal Health has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500.
Cardinal Health currently has a consensus target price of $107.57, indicating a potential upside of 12.36%. Cencora has a consensus target price of $233.90, indicating a potential upside of 8.45%. Given Cencora's higher possible upside, equities research analysts plainly believe Cardinal Health is more favorable than Cencora.
Cencora has a net margin of 0.67% compared to Cencora's net margin of 0.25%. Cardinal Health's return on equity of 268.67% beat Cencora's return on equity.
Cardinal Health pays an annual dividend of $2.00 per share and has a dividend yield of 2.1%. Cencora pays an annual dividend of $2.04 per share and has a dividend yield of 0.9%. Cardinal Health pays out 88.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cencora pays out 22.3% of its earnings in the form of a dividend. Cardinal Health has raised its dividend for 27 consecutive years and Cencora has raised its dividend for 14 consecutive years. Cardinal Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
87.2% of Cardinal Health shares are owned by institutional investors. Comparatively, 97.5% of Cencora shares are owned by institutional investors. 0.2% of Cardinal Health shares are owned by company insiders. Comparatively, 15.8% of Cencora shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Cencora has higher revenue and earnings than Cardinal Health. Cencora is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.
In the previous week, Cencora had 16 more articles in the media than Cardinal Health. MarketBeat recorded 35 mentions for Cencora and 19 mentions for Cardinal Health. Cencora's average media sentiment score of 0.69 beat Cardinal Health's score of 0.17 indicating that Cardinal Health is being referred to more favorably in the media.
Cardinal Health received 167 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 71.70% of users gave Cardinal Health an outperform vote while only 65.12% of users gave Cencora an outperform vote.
Summary
Cencora beats Cardinal Health on 12 of the 20 factors compared between the two stocks.
Get Cencora News Delivered to You Automatically
Sign up to receive the latest news and ratings for COR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding COR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
